Sign inJoin waitlistJoin the waitlist

Jyoti Mayadev

Section Chief · University of California (San Diego) Medical Center

Credentials: · · · ·

History

University of Washington School of Medicine
2005–2009
Preliminary or Transitional Year
2004–2005
Case Western Reserve Univ Sch of Med
2000–2004
Case Western Reserve University 2000
1996–2000

Research

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results…
BJU international · 2012 · 359 citations
Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
Practical Radiation Oncology · 2020 · 211 citations
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
The Lancet Oncology · 2023 · Last of 29 authors · 186 citations

Loren Mell
22 papers
Catheryn Yashar
21 papers
Dominique Rash
16 papers · 5 as a resident
John Einck
14 papers
Casey Williamson
13 papers · 13 as a resident
Richard Valicenti
13 papers
BD
Brandon Dyer
12 papers · 4 as a resident
Bradley Monk
10 papers
Junzo Chino
10 papers
Kevin Albuquerque
9 papers
Michael McHale
9 papers
Arno Mundt
8 papers

Grants

NCI Clinical Trial Research Strategy, Harnessing Innovation, and Implementation
National Cancer Institute · R50
Contact PI · $695.7K · University of California, San Diego
2023–2028

Clinical trials

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Principal investigator · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
Principal investigator · Recruiting
University of California, San Diego
2025–2027
Quantifying Radiation Induced Vaginal Stenosis
Principal investigator · Recruiting
University of California, San Diego
2022–2027
Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
Principal investigator · Recruiting
Varian, a Siemens Healthineers Company
2022–2030